Lupinus polyphyllus Lindl., common name garden lupin, is used in commercial, private, and public landscapes and sold as a cut flower. During summer 2011, extensive brown necrotic areas were observed on young and old leaves of plants grown in a private garden near Biella (northern Italy). The disease affected about 50 of 80 2-year-old plants. Early symptoms included circular to irregular-shaped brown lesions of alternating pale and dark brown concentric bands. Lesions coalesced and often were surrounded by chlorotic halos at an advanced development stage. Lesion expansion was not limited by leaf veins. When lesions covered much of the leaf area, the leaf curled and remained attached. However, expansion of stem lesions often resulted in plant death. A fungus was consistently isolated from 15 infected leaves on potato dextrose agar (PDA). Cultures were grown at 21 to 25°C under 16 h of light and 8 h of darkness. Mature colonies were dark olive-green and produced orangeochre pigments in the medium. Ten isolates were obtained and three strains were used in the morphological study. The mycelium had olivaceous, septate hyphae that produced abundant dark, intercalary chlamydospores. The conidia were cylindrical to elliptical, slightly curved, with a truncated base, five to seven transverse septa and three hyaline appendages. Apical and basal cells were subhyaline, whereas the intermediate cells were olivebrown. The conidia measured 76 to 94 × 14 to 19 (average 85 × 16) μm. Appendages were up to 84 μm long. On the basis of its morphological characteristics the pathogen was identified as Pleiochaeta setosa Kirchn. DNA was extracted using Terra PCR Direct Polymerase Mix (Clontech). The internal transcribed spacer region of rDNA was amplified using primers ITS 1 and 4 (4) and sequenced. BLAST analysis (1) of the 570 bp fragment showed a 100% homology with a P. setosa isolate submitted to GenBank (accession no. EU167563). The nucleotide sequence was submitted to GenBank (JQ358708). Pathogenicity was verified on healthy 5-month-old garden lupin plants by placing 8-mm mycelial disks from 15-day-old cultures on 10 unwounded leaves per plant with five plants per treatment. Ten leaves of five plants were inoculated with PDA disks to serve as a negative control. Plants were covered with plastic bags for 4 days after inoculation and maintained in a growth chamber at 20 ± 1°C. Lesions developed on 80% of leaves 3 days after inoculation, whereas control plants remained healthy. P. setosa was consistently isolated from these lesions. The pathogenicity test was carried out twice. The presence of P. setosa on L. polyphyllus was reported in Australia, United States (2), and Poland (3). This is, to our knowledge, the first report of P. setosa in Italy. The impact of this disease is currently limited. References: (1) S. F. Altschul et al. Nucleic Acids Res., 25:3389, 1997. (2) A. M. French. California Plant Disease Host Index. Calif. Dept. Food Agric. Sacramento, 1989. (3) W. Mulenko et al. A Preliminary Checklist of Mycromycetes in Poland Polish Academy of Sciences, 1982. (4) T. J. White et al. PCR Protocols: A Guide to Methods and Applications. M. A. Innis et al., eds. Academic Press, San Diego, 1990.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1094/PDIS-02-12-0156-PDN | DOI Listing |
Sci Rep
November 2024
SYSNAV, Paris, France.
Stride velocity 95th centile (SV95C) is a wearable-derived endpoint representing the 5% fastest strides taken during everyday living. In July 2023, SV95C received European Medicines Agency (EMA) qualification for use as a primary endpoint in trials of patients with Duchenne muscular dystrophy (DMD) aged ≥ 4 years-becoming the first digital endpoint to receive such qualification. We present the data supporting this qualification, providing insights into the evidentiary basis of qualification as a digital clinical outcome assessment.
View Article and Find Full Text PDFCirc Heart Fail
October 2024
Division of Cardiovascular Medicine, (H.L., S.C., S.L., M.A., A.K., K.K.T., B.L.C., N.P., X.W., M.A.P., S.M.H., S.D.S., H.S.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Diabetologia
January 2025
Department of Medicine and Therapeutics, Hong Kong Institute of Diabetes and Obesity and Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.
A panel of primary care and diabetes specialists conducted focused literature searches on the current role of glycaemic control in the management of type 2 diabetes and revisited the evolution of evidence supporting the importance of early and intensive blood glucose control as a central strategy to reduce the risk of adverse long-term outcomes. The optimal approach to type 2 diabetes management has evolved over time as the evidence base has expanded from data from trials that established the role of optimising glycaemic control to recent data from cardiovascular outcomes trials (CVOTs) demonstrating organ-protective effects of newer glucose-lowering drugs (GLDs). The results from these CVOTs were derived mainly from people with type 2 diabetes and prior cardiovascular and kidney disease or multiple risk factors.
View Article and Find Full Text PDFJ Exp Bot
September 2024
School of Biology and Environmental Science, University College Dublin, Belfield, Dublin 4, Ireland.
Clin Transl Sci
May 2024
Neurocrine Biosciences, Inc, San Diego, California, USA.
This parallel-arm, phase I study investigated the potential cytochrome P450 (CYP)3A induction effect of NBI-1065845 (TAK-653), an investigational α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor potentiator in phase II development for major depressive disorder. The midazolam treatment arm received the sensitive CYP3A substrate midazolam on Day 1, followed by NBI-1065845 alone on Days 5-13; on Day 14, NBI-1065845 was administered with midazolam, then NBI-1065845 alone on Day 15. The oral contraceptive treatment arm received ethinyl estradiol-levonorgestrel on Day 1, then NBI-1065845 alone on Days 5-13; on Day 14, NBI-1065845 was administered with ethinyl estradiol-levonorgestrel, then NBI-1065845 alone on Days 15-17.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!